Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine

Overview of attention for article published in Pharmacogenetics and Genomics, September 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 1,304)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 5,728 followers.

Most Popular: Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafa... http://t.co/A5pgxTsFBO

Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy... http://t.co/s2OVInpkDC

PAP: Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine mono... http://t.co/bd1jzyuB3g

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.